Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

Proactive news headlines: Ondine, Ilika, Graft Polymer, Chill Brands, Cornish Metal

Antipa Minerals Ltd (ASX:AZY) is set to kick off phase two of its 2023 drill campaign at the wholly-owned Minyari Dome Gold-Copper Project in Western Australia's Paterson Province.

This large-scale program will include up to 19,200 metres of new reverse circulation (RC), diamond core and aircore drilling, targeting existing gold-copper resources and new greenfield discoveries.

Read more

OKYO Pharma Ltd (NASDAQ:OKYO), the clinical-stage drug developer, told investors it has filed an Investigational New Drug (IND) application with the US Food and Drug Administration (FDA) for the development of OK-101 to treat Neuropathic Corneal Pain (NCP).

According to the company, there is no FDA-approved drug to treat NCP, which remains a major unmet medical need for the ocular community. The trial provides the opportunity to establish OK-101’s potential to treat this condition, it added.

Read more

Ilika PLC (AIM:IKA, OTCQX:ILIKF), a specialist in solid-state battery technology, has landed a £400,000 grant from the Automotive Transformation Fund (ATF) to enhance its Goliath pilot production capabilities.

The funding is part of a 16-month, £2.7 million collaboration programme that kicked off on 1 October. Ilika is collaborating with Mpac Group (LSE:MPAC) PLC and the UK Battery Industrialisation Centre (UKBIC) for this initiative.

Read more

Graft Polymer (UK) PLC has joined a consortium led by the Vinca Institute of Nuclear Sciences relating to the GrinShield Project Twinning programme for new graphene-based composites in electromagnetic interference shielding.

The initiative, supported by French, German and Slovenian teams, was formed in response to the growing demand for materials that can mitigate the effects of electromagnetic waves (EWs).

Read more

Ondine Biomedical Inc (AIM:OBI)'s Steriwave nasal photodisinfection technology has been adopted by Penticton Regional Hospital (PRH) in British Columbia as a standard-of-care measure for patients undergoing orthopaedic surgeries.

Affiliated with the University of British Columbia's Faculty of Medicine, PRH conducts approximately 900 of these types of procedures a year.

Read more

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK